TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10871716

Group type: EXPERIMENTAL
Intervention: Computerized EORTC QLQ‐C30 questionnaire
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 8674333

Group type: EXPERIMENTAL
Intervention: Hygroster (group 1, n = 7)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hygrobac-S (group 2, n = 7)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard heated hot water humidifier (control)
Number of subjects: 14
Study: 1687129

Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms b.i.d.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Salbutamol 200 micrograms b.i.d.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Formoterol (with inhaled steroids reintroduced)
Number of subjects: 18
Study: 6376908

Group type: EXPERIMENTAL
Intervention: High opsonic activity against S. epidermidis in peritoneal dialysis effluent
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low opsonic activity against S. epidermidis in peritoneal dialysis effluent
Number of subjects: 17

Group type: COMPARATOR
Intervention: Peritoneal dialysis effluent
Number of subjects: 17

Group type: COMPARATOR
Intervention: Peritonitis episodes
Number of subjects: 17
Study: 29717908

Group type: EXPERIMENTAL
Intervention: GreenLight laser vaporization (Group A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Thulium laser enucleation (Group B)
Number of subjects: 150
Study: 26385187

Group type: EXPERIMENTAL
Intervention: ARV metal stent (ARVMS)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional covered SEMS (cSEMS)
Number of subjects: 77
Study: 24597915

Group type: EXPERIMENTAL
Intervention: Personal feedback report distributed to clients and counselors
Number of subjects: 79

Group type: COMPARATOR
Intervention: Personal feedback report distributed only to clients
Number of subjects: 79

Group type: COMPARATOR
Intervention: No personal feedback report
Number of subjects: 79
Study: 23740589

Group type: EXPERIMENTAL
Intervention: Functional Circuit Training (FCT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 51
Study: 19346013

Group type: EXPERIMENTAL
Intervention: Off-pump surgery
Number of subjects: 26

Group type: COMPARATOR
Intervention: On-pump surgery
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study: 19049377

Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: BIAsp 50
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: BIAsp 70
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: IAsp
Number of subjects: 32
Study: 15876899

Group type: EXPERIMENTAL
Intervention: Bupropion sustained-release 300 mg/d
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 11042232

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention
Number of subjects: 1504

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 1504
Study: 9035450

Group type: COMPARATOR
Intervention: hypocaloric diet + placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: hypocaloric diet + dexfenfluramine
Number of subjects: 39

Group type: COMPARATOR
Intervention: hypocaloric diet + spiruline + fucus + gelatin
Number of subjects: 39
Study: 1494509

Group type: EXPERIMENTAL
Intervention: Paretic arm of patients with spastic stroke
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Paretic arm of patients with flaccid tone
Number of subjects: 103

Group type: COMPARATOR
Intervention: Blood pressure measurement in unaffected arm
Number of subjects: 103
Study: 3887883

Group type: COMPARATOR
Intervention: Cholestyramine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cholestyramine + Neomycin
Number of subjects: 18
Study: 31450853

Group type: EXPERIMENTAL
Intervention: CHW-led multimedia intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 42
Study: 29308992

Group type: EXPERIMENTAL
Intervention: Goal-setting intervention
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Goal-setting with mentoring intervention
Number of subjects: 75
Study: 27324341

Group type: EXPERIMENTAL
Intervention: Probiotic SYNBIO(®) vaginal suppositories (Lactobacillus rhamnosus IMC 501(®) and Lactobacillus paracasei IMC 502(®)) administered daily for 7 days
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Probiotic SYNBIO(®) vaginal suppositories
Number of subjects: 35
Study: 24804879

Group type: EXPERIMENTAL
Intervention: Cortisol levels
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Rate of change in cortisol
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: CES-D
Number of subjects: 227

Group type: COMPARATOR
Intervention: Adrenocorticotropin hormone, epinephrine, and norepinephrine
Number of subjects: 227
Study: 22290808

Group type: EXPERIMENTAL
Intervention: CCSP (self-management comprehensive coping strategy program)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study: 20202012

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) procedure
Number of subjects: 360
Study: 18367110

Group type: EXPERIMENTAL
Intervention: Cytoreductive nephrectomy followed by interferon treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tyrosine kinase inhibitors (TKIs)
Number of subjects: 0
Study: 16846328

Group type: EXPERIMENTAL
Intervention: Video intervention for participants with high or moderate levels of extraversion
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Higher perceived risk at baseline
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Higher perceived risk
Number of subjects: 697
Study: 12798887

Group type: EXPERIMENTAL
Intervention: Depot triptorelin for 8 weeks before myomectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Immediate surgery
Number of subjects: 100
Study: 10834688

Group type: EXPERIMENTAL
Intervention: Hygroscopic HME (Aqua+) changed every 24 hrs (HHME‐24)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Hydrophobic HME (Duration HME) changed every 120 hrs (HME‐120)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Hygroscopic HME (Aqua+) changed every 120 hrs (HHME‐120)
Number of subjects: 220
Study: 8993854

Group type: EXPERIMENTAL
Intervention: Angiotensin receptor antagonists (AT1 antagonists)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin receptor antagonists (AT1 antagonists) with diuretic
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term studies
Number of subjects: 0
Study: 1614693

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 100
Study: 4033401

Group type: EXPERIMENTAL
Intervention: Dehydration (D) with 40 mg of furosemide
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dehydration (D) during treadmill exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normally hydrated (H) during treadmill exercise
Number of subjects: 8
Study: 31860106

Group type: EXPERIMENTAL
Intervention: Top-cited articles in nonspecialty journals
Number of subjects: 278846

Group type: COMPARATOR
Intervention: Top-cited articles in OBGYN journals
Number of subjects: 278846
Study: 29244956

Group type: EXPERIMENTAL
Intervention: CHO
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: BCAA
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: CHO+BCAA
Number of subjects: 13

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 13
Study: 27785923

Group type: EXPERIMENTAL
Intervention: Trimethoprim‐sulfamethoxazole (TMP‐SMX) prophylaxis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lactobacilli prophylaxis
Number of subjects: 40
Study: 25305538

Group type: EXPERIMENTAL
Intervention: Training by undergraduates alone
Number of subjects: 0
Study: 21932036

Group type: EXPERIMENTAL
Intervention: Maximal Androgen Blockade (MAB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: More Maximal Androgen Blockade (mMAB)
Number of subjects: 63
Study: 20508478

Group type: EXPERIMENTAL
Intervention: PHiD‐CV and MMRV vaccine
Number of subjects: 325

Group type: COMPARATOR
Intervention: DTPa‐HBV‐IPV/Hib and MMRV vaccines
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: PHiD‐CV and DTPa‐HBV‐IPV/Hib vaccine
Number of subjects: 325
Study: 17494311

Group type: EXPERIMENTAL
Intervention: Chondroxide phonophoresis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phinalgel phonophoresis
Number of subjects: 0
Study: 18317317

Group type: EXPERIMENTAL
Intervention: Caring group experiences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ropes course experiences
Number of subjects: 0
Study: 15315997

Group type: EXPERIMENTAL
Intervention: Vitamin E (200 IU) daily
Number of subjects: 617
Study: 12230176

Group type: EXPERIMENTAL
Intervention: Cryptosporidium parvum isolate IOWA
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cryptosporidium parvum isolate TAMU
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cryptosporidium parvum isolate UCP
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Mixture of the three isolates (IOWA, TAMU, UCP)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Random oocyst from the larger population of strains
Number of subjects: 3
Study: 9296325

Group type: EXPERIMENTAL
Intervention: Pranlukast (300 mg) administered in the evening after a high fat meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Pranlukast (300 mg) administered in the morning after a high fat meal
Number of subjects: 12
Study: 8191447

Group type: EXPERIMENTAL
Intervention: Standard dosage of chloramphenicol eyedrops (0.5% eye drops, one drop hourly/every two hours for three days, thereafter every 4‐6 hours)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Simplified dosage of chloramphenicol eyedrops (four times a day)
Number of subjects: 152
Study: 3075473

Group type: EXPERIMENTAL
Intervention: Euro‐Collins' solution (ECS; n = 9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ringer's solution (RS; n = 9)
Number of subjects: 18
Study: 31096958

Group type: EXPERIMENTAL
Intervention: Green exercise and balneotherapy (GEBT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Green exercise (GE)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (CO)
Number of subjects: 80
Study: 28236262

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Aromatherapy
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control (rest only; noise-canceling headphones)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Music intervention and Aromatherapy
Number of subjects: 132
Study: 26220533

Group type: EXPERIMENTAL
Intervention: Formoterol 12 μg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Salmeterol 50 μg
Number of subjects: 16
Study: 22617860

Group type: EXPERIMENTAL
Intervention: Modafinil 255 mg daily
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Modafinil 340 mg daily
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Modafinil 425 mg daily
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Modafinil 510 mg daily
Number of subjects: 338

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study: 22015077

Group type: EXPERIMENTAL
Intervention: Elvitegravir 150 mg once daily
Number of subjects: 724

Group type: COMPARATOR
Intervention: Raltegravir 400 mg twice daily
Number of subjects: 724
Study: 19490952

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Antireflux surgery
Number of subjects: 310
Study: 17766504

Group type: EXPERIMENTAL
Intervention: High-intensity practices (3 practices)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-intensity practices (17 practices)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control practices
Number of subjects: 20
Study: 16305290

Group type: EXPERIMENTAL
Intervention: Bitter-orange dried-fruit extract (450 mg standardized to 27 mg of m- or p-synephrine)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12001541

Group type: EXPERIMENTAL
Intervention: Subcutaneous enoxaparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous heparin/oral phenprocoumon
Number of subjects: 0
Study: 9459074

Group type: EXPERIMENTAL
Intervention: Hypertensive individuals
Number of subjects: 99

Group type: COMPARATOR
Intervention: Normotensive individuals
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Hypertensive individuals and Normotensive individuals
Number of subjects: 99
Study: 7534217

Group type: EXPERIMENTAL
Intervention: Atropine 10 micrograms.kg‐1 and succinylcholine 1.5 mg.kg‐1 (n = 12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Atropine 20 micrograms.kg‐1 and succinylcholine 1.5 mg.kg‐1 (n = 13)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vecuronium 0.1 mg.kg‐1 (n = 11)
Number of subjects: 36
Study: 2774849

Group type: EXPERIMENTAL
Intervention: Bright light exposure (phototherapy) for individuals with subsyndromal seasonal affective disorder, 5 hours divided between morning and evening.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bright light exposure (phototherapy) for individuals with subsyndromal seasonal affective disorder, 2 hours exposure.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bright light exposure (phototherapy) for healthy individuals (controls).
Number of subjects: 20
Study: 334477

Group type: EXPERIMENTAL
Intervention: 300 mg flurbiprofen daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 150 mg indomethacin daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of flurbiprofen and indomethacin
Number of subjects: 30
Study: 30768161

Group type: EXPERIMENTAL
Intervention: 14 day high-dose dual therapy (esomeprazole 40 mg three times daily and amoxicillin 750 mg four times daily for 14 days)
Number of subjects: 240

Group type: COMPARATOR
Intervention: 7 day non-bismuth quadruple therapy (esomeprazole 40 mg twice daily, clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily and metronidazole 500 mg twice daily for 7 days)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 14 day high-dose dual therapy
Number of subjects: 240

Group type: COMPARATOR
Intervention: 7 day non-bismuth quadruple therapy
Number of subjects: 240
Study: 28593734

Group type: EXPERIMENTAL
Intervention: NTI-tss device integrated with guidance, assurance, counselling and behavioural changes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Guidance, assurance, counselling and behavioural changes
Number of subjects: 40
Study: 25462663

Group type: COMPARATOR
Intervention: Stimulant Craving Questionnaire (STCQ) for methamphetamine users
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Stimulant Craving Questionnaire (STCQ) for cocaine users
Number of subjects: 301
Study: 23504241

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 21856349

Group type: EXPERIMENTAL
Intervention: HPV co-administered with HepB
Number of subjects: 741

Group type: COMPARATOR
Intervention: HepB alone
Number of subjects: 741

Group type: COMPARATOR
Intervention: HPV alone
Number of subjects: 741
Study: 19687085

Group type: EXPERIMENTAL
Intervention: Modified Cold Provocation Test
Number of subjects: 176
Study: 17291993

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (healthy individuals)
Number of subjects: 45
Study: 15482068

Group type: EXPERIMENTAL
Intervention: Conflict monitoring in an attentional task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N2 scalp potential
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-error conflict detection
Number of subjects: 0
Study: 11465582

Group type: EXPERIMENTAL
Intervention: 5-10 minute discussion led by anesthesiologists about end-of-life care communication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard preoperative anesthesia screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-10 minute discussion led by anesthesiologists
Number of subjects: 0
Study: 8167653

Group type: EXPERIMENTAL
Intervention: Postexercise glucose ingestion (100 g glucose polymer drink)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Postexercise glucose ingestion with potassium chloride (3 g KCl)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (glucose drink alone)
Number of subjects: 13
Study: 2850604

Group type: EXPERIMENTAL
Intervention: s.c. injection of 8 micrograms alsactide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: s.c. injection of 10 micrograms alsactide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: s.c. injection of 20 micrograms alsactide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: i.v. injection of 2 micrograms alsactide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: i.v. injection of 4 micrograms alsactide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: i.v. injection of 8 micrograms alsactide
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo (isotonic saline)
Number of subjects: 10
Study: 31231369

Group type: COMPARATOR
Intervention: Tear lysozyme concentration (Lys-C) in individuals with URTI
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tear lysozyme secretion rates (Lys-SR) in individuals with URTI
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tear lactoferrin secretion rates (Lf-SR) in individuals with URTI
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Tear AMP secretion rates post-exercise
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Tear AMP concentrations during dehydration
Number of subjects: 26
Study: 27933616

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 92
Study: 26025212

Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling plus brochures
Number of subjects: 158

Group type: COMPARATOR
Intervention: Non-tailored print brochures
Number of subjects: 158
Study: 23691830

Group type: EXPERIMENTAL
Intervention: System 2 (stereo headphones)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: System 3 (stereo headphones and a bone conduction vibrator)
Number of subjects: 18

Group type: COMPARATOR
Intervention: System I (three loudspeakers)
Number of subjects: 18
Study: 21517963

Group type: EXPERIMENTAL
Intervention: Educative questionnaire about SIDS
Number of subjects: 292
Study: 19335435

Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus ointment applied twice daily for 8 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal controls (no treatment)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus ointment
Number of subjects: 8
Study: 16732472

Group type: EXPERIMENTAL
Intervention: Social cognition enhancement training (SCET) plus standard psychiatric rehabilitation training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard psychiatric rehabilitation training only
Number of subjects: 34
Study: 14672612

Group type: EXPERIMENTAL
Intervention: Vitamin E (1000 I.U. per day for 3 months)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 51
Study: 11385906

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical procedures (organ preserving or reconstructive techniques)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical interaction
Number of subjects: 0
Study: 9508170

Group type: EXPERIMENTAL
Intervention: Interferon plus prednisone (IFN/P)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Interferon (IFN)
Number of subjects: 233
Study: 8071269

Group type: EXPERIMENTAL
Intervention: 10 mg zolpidem
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 15 mg zolpidem
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 3052188

Group type: EXPERIMENTAL
Intervention: New formulation of Rhinalar (less propylene glycol)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Original formulation of Rhinalar
Number of subjects: 122
Study: 31450175

Group type: EXPERIMENTAL
Intervention: C-MAC videolaryngoscope view
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Miller blade
Number of subjects: 96

Group type: COMPARATOR
Intervention: Miller and Wis-Hipple and direct C-MAC views
Number of subjects: 96
Study: 30657434

Group type: EXPERIMENTAL
Intervention: e-SBI
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Text messaging
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: e-SBI plus text messaging
Number of subjects: 45
Study: 28656612

Group type: EXPERIMENTAL
Intervention: Caloric vestibular stimulation (CVS) device (TNM™), 3-month treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 25979566

Group type: EXPERIMENTAL
Intervention: 20 g whey protein
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 40 g whey protein
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 60 g whey protein
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 80 g whey protein
Number of subjects: 10

Group type: COMPARATOR
Intervention: All conditions (20, 40, 60, 80 g whey protein)
Number of subjects: 10
Study: 23052408

Group type: EXPERIMENTAL
Intervention: Sirolimus administered simultaneously with tacrolimus
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sirolimus administered staggered after tacrolimus
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tacrolimus administered simultaneously with sirolimus
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tacrolimus administered staggered before sirolimus
Number of subjects: 27
Study: 21526394

Group type: EXPERIMENTAL
Intervention: FOUR score
Number of subjects: 176

Group type: COMPARATOR
Intervention: GLS/GCS
Number of subjects: 176
Study: 19222510

Group type: EXPERIMENTAL
Intervention: Tonabersat 20 mg daily for 2 weeks and 40 mg daily for a further 10 weeks
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Tonabersat
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 16516013

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 737
Study: 14747388

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCT) in nephrology
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Standard guidelines and checklists for trial reporting
Number of subjects: 430